UK markets close in 3 hours 3 minutes

Inhibikase Therapeutics, Inc. (IKT)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
1.8900+0.0300 (+1.61%)
At close: 04:00PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts2222
Avg. Estimate-0.56-0.57-2.02-1.48
Low estimate-0.76-0.78-2.33-1.52
High estimate-0.37-0.37-1.71-1.44
Year ago EPS-1.11-0.86-3.57-2.02
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts2222
Avg. EstimateN/AN/AN/AN/A
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/AN/A
Year ago salesN/AN/A260kN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.92-1.12-0.85-0.79
Actual EPS-1.11-0.86-0.64-0.73
Difference-0.190.260.210.06
Surprise %-20.70%23.20%24.70%7.60%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.56-0.57-2.02-1.48
7 days ago-0.37-0.37-1.77-1.49
30 days ago-0.37-0.37-1.77-1.49
60 days ago-0.37-0.37-1.77-1.49
90 days ago-0.37-0.37-1.77-1.49
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/A1
Up last 30 daysN/AN/AN/A1
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/A1N/A
Growth estimatesIKTIndustrySector(s)S&P 500
Current qtr.49.50%N/AN/AN/A
Next qtr.33.70%N/AN/AN/A
Current year43.40%N/AN/AN/A
Next year26.70%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A